Export 114 results:
Author [ Title(Asc)] Type Year
Filters: Author is Saraiva, M.J.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Soares, M. L., Coelho, T., Sousa, A., Batalov, S., et al. (2005). Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: Complexity in a single-gene disease. Human Molecular Genetics, 14(4), 543 - 553.
Niederhauser, J., Lobrinus, J. A., Ochsner, F., Wider, C., et al. (2011). Successful heart and liver transplantation in a swiss patient with glu89lys transthyretin amyloidosis. Transplantation, 91(6), e40 - e42.
Pires, R. H., Saraiva, M. J., Damas, A. M., & Kellermayer, M. S. Z. (2011). Structure and assembly-disassembly properties of wild-type transthyretin amyloid protofibrils observed with atomic force microscopy. Journal of Molecular Recognition, 24(3), 467 - 476.
Castro-Rodrigues, A. F., Gales, L., Saraiva, M. J., & Damas, A. M. (2011). Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils. Acta Crystallographica Section D: Biological Crystallography, 67(12), 1035 - 1044.
Gales, L., Saraiva, M. J., & Damas, A. M. (2007). Structural basis for the protective role of sulfite against transthyretin amyloid formation. Biochimica et Biophysica Acta - Proteins and Proteomics, 1774(1), 59 - 64.
Ribeiro, C. A., Saraiva, M. J., & Cardoso, I. (2012). Stability of the Transthyretin Molecule as a Key Factor in the Interaction with A-Beta Peptide - Relevance in Alzheimer's Disease. PLoS ONE, 7(9).
Sárkány, Z., Ikonen, T. P., Ferreira-Da-Silva, F., Saraiva, M. J., et al. (2011). Solution structure of the soluble receptor for advanced glycation end products (sRAGE). Journal of Biological Chemistry, 286(43), 37525 - 37534.
Almeida, M. R., Gales, L., Damas, A. M., Cardoso, I., & Saraiva, M. J. (2005). Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses. Current Drug Targets: CNS and Neurological Disorders, 4(5), 587 - 596.
Almeida, M. R., Macedo, B., Cardoso, I., Alves, I., et al. (2004). Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative. Biochemical Journal, 381(2), 351 - 356.
R
Saraiva, A. M., Cardoso, I., Saraiva, M. J., Tauer, K., et al. (2010). Randomization of Amyloid-β-Peptide(1-42) Conformation by Sulfonated and Sulfated Nanoparticles Reduces Aggregation and Cytotoxicity. Macromolecular Bioscience, 10(10), 1152 - 1163.
P
Gonçalves, N. P., Teixeira-Coelho, M., & Saraiva, M. J. (2015). Protective role of anakinra against transthyretin-mediated axonal loss and cell death in a mouse model of familial amyloidotic polyneuropathy. Journal of Neuropathology and Experimental Neurology, 74(3), 203 - 217.
Quintela, T., Gonçalves, I., Martinho, A., Alves, C. H., et al. (2011). Progesterone enhances transthyretin expression in the rat choroid plexus in vitro and in vivo via progesterone receptor. Journal of Molecular Neuroscience, 44(3), 152 - 158.
Westermark, P., Benson, M. D., Buxbaum, J. N., Cohen, A. S., et al. (2007). A primer of amyloid nomenclature. Amyloid, 14(3), 179 - 183.
Teixeira, A. C., & Saraiva, M. J. (2013). Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: An escape from ERAD. Journal of Cellular and Molecular Medicine, 17(3), 429 - 435.
Butler, J. S., Chan, A., Costelha, S., Fishman, S., et al. (2016). Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis. Amyloid, 23(2), 109 - 118.
Conejos-Sánchez, I., Cardoso, I., Oteo-Vives, M., Romero-Sanz, E., et al. (2015). Polymer-doxycycline conjugates as fibril disrupters: An approach towards the treatment of a rare amyloidotic disease. Journal of Controlled Release, 198, 80 - 90.
O
Gonçalves, N. P., Martins, D., & Saraiva, M. J. (2016). Overexpression of Protocadherin-10 in Transthyretin-Related Familial Amyloidotic Polyneuropathy. American Journal of Pathology, 186(7), 1913 - 1924.
N
Gonçalves, N. P., Oliveira, H., Pêgo, A. P., & Saraiva, M. J. (2012). A novel nanoparticle delivery system for in vivo targeting of the sciatic nerve: Impact on regeneration. Nanomedicine, 7(8), 1167 - 1180.
Simões, C. J. V., Almeida, Z. L., Costa, D., Jesus, C. S. H., et al. (2016). A novel bis-furan scaffold for transthyretin stabilization and amyloid inhibition. European Journal of Medicinal Chemistry, 121, 823 - 840.
Ferreira, N., Saraiva, M. J., & Almeida, M. R. (2011). Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation. FEBS Letters, 585(15), 2424 - 2430.
Ferreira, N., Saraiva, M. J., & Almeida, M. R. (2012). Natural polyphenols as modulators of TTR amyloidogenesis: In vitro and in vivo evidences towards therapy. Amyloid, 19(SUPPL. 1), 39 - 42.
M
De Carvalho, M., Linke, R. P., Domingos, F., Evangelista, T., et al. (2004). Mutant fibrinogen A-α-chain associated with hereditary renal amyloidosis and peripheral neuropathy. Amyloid, 11(3), 200 - 207.
Pansieri, J., Plissonneau, M., Stransky-Heilkron, N., Dumoulin, M., et al. (2017). Multimodal imaging Gd-nanoparticles functionalized with Pittsburgh compound B or a nanobody for amyloid plaques targeting. Nanomedicine, 12(14), 1675 - 1687.
Martins, D., Moreira, J., Gonçalves, N. P., & Saraiva, M. J. (2017). MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy. DMM Disease Models and Mechanisms, 10(10), 1253 - 1260.
I
González, A., Quirante, J., Nieto, J., Almeida, M. R., et al. (2009). Isatin derivatives, a novel class of transthyretin fibrillogenesis inhibitors. Bioorganic and Medicinal Chemistry Letters, 19(17), 5270 - 5273.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@i3s.up.pt | © copyright 2010 ibmc